Literature DB >> 2580178

Effects of captopril, hydrochlorothiazide, and their combination on timed urinary excretions of water and solutes.

W P Leary, A J Reyes, K V van der Byl, T N Acosta-Barrios.   

Abstract

The effects of single doses of captopril 100 mg, hydrochlorothiazide 25 mg, and a combination of both on 24-h outputs of fluid and several solutes were compared in healthy volunteers. Thirteen subjects were studied in a metabolic ward under strictly controlled conditions. Single doses of placebo, captopril, hydrochlorothiazide, and a combination of captopril and hydrochlorothiazide were given double-blind in random order on 4 separate days. Urine was collected at regular intervals for 24 h after medication. The combination of captopril and hydrochlorothiazide and hydrochlorothiazide alone significantly increased the 24-h urinary outputs of Cl-, Na+, fluid, and K+ compared with placebo and also accelerated the corresponding urinary flows. Captopril did not change the 24-h urinary excretions of Cl-, Na+, fluid, and K+ significantly, though it advanced the time courses of their urinary flows. All medications significantly increased the 24-h renal outputs of Mg2+ and creatinine. Captopril significantly increased the 24-h urinary output of urate and advanced its urinary flow. Hydrochlorothiazide significantly decreased the output and retarded the flow. The combination of captopril and hydrochlorothiazide did not change the 24-h urinary output and retarded its flow. It is concluded that the renal excretory actions of captopril are more prolonged than the plasma levels of the drug would indicate. Captopril has diuretic effects which may vary in potency with aldosterone concentrations and uricosuric properties unrelated to aldosterone status.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580178     DOI: 10.1097/00005344-198507001-00012

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 2.  Clinicopharmacological reappraisal of the potency of diuretics.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 3.  Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 4.  Do diuretics cause magnesium deficiency?

Authors:  D L Davies; R Fraser
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

5.  Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.

Authors:  A F Lant
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

6.  The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.

Authors:  H Knauf; M A Bailey; G Hasenfuss; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  2006-09-09       Impact factor: 2.953

Review 7.  Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.

Authors:  A J Reyes
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 8.  Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications.

Authors:  Nicole Leung; Kevin Yip; Michael H Pillinger; Michael Toprover
Journal:  Mayo Clin Proc       Date:  2022-07       Impact factor: 11.104

9.  Captopril + hydrochlorothiazide 24 h ambulatory monitoring effects.

Authors:  R G Asmar; B M Pannier; C J Hugue; S Laurent; A Safavian; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

Review 10.  Angiotensin I converting enzyme inhibitors and the renal excretion of urate.

Authors:  W P Leary; A J Reyes
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.